RWC Asset Management LLP - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RWC Asset Management LLP ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$6,604,000
-6.8%
6,500,0000.0%0.20%
-15.3%
Q4 2020$7,085,000
+31.9%
6,500,000
+25.0%
0.24%
+9.3%
Q3 2020$5,373,000
-2.3%
5,200,000
+4.0%
0.22%
-13.3%
Q2 2020$5,499,000
+18.5%
5,000,000
+9.9%
0.25%
+5.5%
Q1 2020$4,642,000
-7.8%
4,550,000
+3.4%
0.24%
+15.7%
Q4 2019$5,037,000
+0.5%
4,400,0000.0%0.20%
-4.2%
Q3 2019$5,014,000
-33.1%
4,400,000
-37.1%
0.21%
-58.2%
Q4 2015$7,495,0007,000,0000.51%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2019
NameSharesValueWeighting ↓
Alken Asset Management Ltd 850,000$848,0003.53%
TENOR CAPITAL MANAGEMENT Co., L.P. 34,448,000$35,346,0001.72%
Sonora Investment Management, LLC 9,376,000$9,408,0001.12%
CSS LLC/IL 7,500,000$7,639,0000.60%
IRON Financial LLC 490,000$498,0000.31%
MACKAY SHIELDS LLC 32,910,000$33,383,0000.31%
RWC Asset Management LLP 4,550,000$4,642,0000.24%
Opti Capital Management, LP 1,000$1,024,0000.21%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$4,956,0000.18%
ADVENT CAPITAL MANAGEMENT /DE/ 5,283,000$5,301,0000.12%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders